On Friday, Lincoln National Corporation (NYSE:LNC)’s shares declined -2.04% to $48.40.
Lincoln Financial Group (LNC) declared the next generation of its Lincoln AssetEdge® Variable Universal Life (VUL) insurance offering, featuring expanded investment options for tax-efficient cash accumulation with downside protection, and supplemental income potential, as well as life insurance protection.
In addition to offering clients an income tax-free death benefit and more than 80 market-driven variable investment options from the Lincoln Elite Series of Funds for maximum growth potential, Lincoln AssetEdge® VUL now offers three indexed accounts for moderate growth potential with guaranteed downside protection, and a fixed account for more conservative, predictable growth. Clients have the ability to adjust investment allocations over time to align with changing needs and financial goals.
Lincoln National Corporation, through its auxiliaries, engages in multiple insurance and retirement businesses in the United States. It operates through Annuities, Retirement Plan Services, Life Insurance, and Group Protection segments.
Unum Group (NYSE:UNM)’s shares dropped -2.01% to $32.25.
Unum Group (UNM) stated net income of $224.3 million ($0.90 per diluted common share) for the second quarter of 2015, contrast to net income of $239.4 million ($0.93 per diluted common share) for the second quarter of 2014.
After-tax operating income, which excludes after-tax realized investment gains and losses on the Company’s investment portfolio, counting a second quarter of 2014 hedge gain associated with the retirement of debt, the amortization of preceding period actuarial losses on the Company’s pension plans, and costs related to the second quarter of 2014 early retirement of debt, was $222.6 million ($0.89 per diluted common share) in the second quarter of 2015, contrast to $231.7 million ($0.90 per diluted common share) in the second quarter of 2014. The combined impact of the amounts excluded resulted in a net after-tax gain of $1.7 million ($0.01 per diluted common share) for the second quarter of 2015, contrast to a net after-tax gain of $7.7 million ($0.03 per diluted common share) in the second quarter of 2014.
Unum Group, together with its auxiliaries, provides group and individual disability insurance products in the United States and the United Kingdom. The company operates through three segments: Unum US, Unum UK, and Colonial Life. It provides group long-term and short-term disability, group life, accidental death and dismemberment, individual disability, supplemental and voluntary products, and group and individual long-term care insurance products, in addition to accident, sickness and disability products, life products, and cancer and critical illness products.
At the end of Friday’s trade, Eastman Chemical Company (NYSE:EMN)‘s shares dipped -2.40% to $69.54.
Eastman Chemical Company (EMN) was recognized by the American Chemical Society (ACS) with the Heroes of Chemistry award, an honor reserved by the ACS to celebrate innovative work in chemistry and chemical engineering that led to commercial products benefiting the world. Eastman received the award for the first time ever, and for one of the defining success stories in company history: Eastman Tritan(TM) copolyester.
The ACS bestowed the awards to Eastman and five other companies at the ACS National Meeting in Boston. Six scientists and engineers who were integral to the Tritan(TM) commercialization effort accepted the award on behalf of Eastman: Ben Barton, Emmett Crawford, Ted Germroth, Chris Killian, Tony Messina and David Porter.
Eastman Chemical Company, a specialty chemical company, manufactures and sells materials, chemicals, and fibers in the United States and internationally. The company’s Additives & Functional Products segment offers solvents, such as specialty coalescents and ketones and esters, glycol ethers, and alcohol solvents; cellulose and polyester-based specialty polymers, and paint additives; insoluble sulfur products; antidegradants; hydrocarbon resins; specialty intermediates, performance products, and formic acid; and alkylamine derivatives.
CME Group Inc (NASDAQ:CME), ended its Friday’s trading session with -1.47% loss, and closed at $92.43.
CME Group, the world’s leading and most diverse derivatives marketplace, recently declared that July 2015 volume averaged 12.8 million contracts per day, up 5 percent from July 2014. Total volume was more than 282 million contracts, of which 87 percent was traded electronically. Options volume in July averaged 2.9 million contracts per day, up 22 percent as compared to July 2014, with electronic options growing 36 percent over the same period.
CME Group interest rate volume averaged 5.9 million contracts per day in July 2015, down 5 percent contrast with July 2014. Treasury average daily volume rose 3 percent, with treasury futures volume of 2.2 million contracts per day, down 2 percent from the same period a year ago. Treasury options volume grew 27 percent to more than 634,000 contracts per day and comprised of record weekly treasury options average daily volume of 147,707. Eurodollar futures volume averaged 2.1 million contracts per day, down 20 percent contrast with July 2014. Eurodollar options volume averaged 927,000 contracts per day, up 14 percent, driven by 62 percent growth in Eurodollar options traded on the CME Globex platform. In July, 21 percent of the Eurodollar options volume traded electronically.
CME Group Inc., through its auxiliaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products for trading and/or clearing across various asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
